Part of the European Research Council’s reasoning for providing their coveted Starting Grants is to “provide top talent with good conditions at the right time to thrive.” For the team led by Fran Supek (b. Zagreb, Croatia, 1981), the right time has just arrived with the award of a Starting Grant worth 1.5 million euros of funding. His project, called HYPER-INSIGHT, was among the 13% of successful proposals of the 3,085 applications made to the 2017 ‘Starting Grants’ Call.
JutarnjiLife, among other media from Croatia and Bosnia Herzegovina, has dedicated a space to Fran Supek, on the occasion of his receiving a Starting Grant from the European Research Council (ERC).
With this award, the ERC allows high-level scientists such as Supek to work long-term, “leading to important discoveries”. In this case, the research will focus on the genomes of hypermutated tumours.
Link to JutarnjiLife (Croatia)
Link to ...
Diario Médico has echoed that Fran Supek, head of the IRB Barcelona Genome Data Science group, has been awarded a Starting Grant from the European Research Council (ERC). This funding will be used to further his project. Supek aims to acquire greater knowledge of cancer biology in order to support the design of individualised therapies. To this end, he will analyse hypermutated tumours.
Link to Diario Médico
ERC Starting Grants support young talented researchers over 5 years.
The IRB Barcelona group leader will focus on the genomes of hypermutated tumours to detect cancer vulnerabilities.
The magazines "GEN" & "Front Line Genomics" have echoed on the study performed by IRB Barcelona group leader Fran Supek and Ben Lehner at the Centre for Genomic Regulation (CRG) in Barcelona.
Published in the journal Cell, the study identifies one of the key mechanisms responsible for mutations caused by a defective DNA ‘spellchecker’—a process that repairs damage in our genomes.
Link to GEN
Link to Front Line Genomics
IRB Barcelona scientist Fran Supek speaks with the Catalan radio programme "Versió RAC1" about his study he did while working at the CRG, published in Cell. The study identifies errors made by the 'DNA spellchecker’ as an important cause of cancer.
Read the news and listen to Fran Supek in RAC1
Fran Supek (IRB Barcelona) and Ben Lehner (CRG) identify important processes that create mutations that cause cancer by studying the genomes of more than 1,000 tumors.
Many mutations in human cancers are caused by mistakes made by a repair mechanism or ‘DNA spellchecker’ rather than the actual damage to DNA caused by the environment.
Sunlight and alcohol consumption increase the rate at which this happens, resulting in more mutations in the most important parts of our genomes.
The local newspaper “El Punt Avui” has included an article about IRB Barcelona's new laboratory for analysis of genomic 'big data', entitled Genome Data Science (aGENDAS).
aGENDAS, headed by Fran Supek, is starting this April and will undertake research in Big Data, a strategic area also for the Barcelona Institute of Science and Technology (BIST).
Link to La Vanguardia
Croatian scientist Fran Supek is launching his Genome Data Science (aGENDAS) laboratory.
aGENDAS is starting this April and will promote the research in Big Data, an strategic area also for the Barcelona Institute of Science and Technology (BIST).
With this new group, the Institute now hosts 24 laboratories and seven core facilities.
As of November, Núria López-Bigas, winner of the 2016 Banco Sabadell Foundation Prize for Biomedical Research, will join IRB Barcelona to continue her research on cancer using computational biology.
The Institute has also recruited Croatian scientist Fran Supek, who will launch his laboratory in 2017.